FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3141560986> ?p ?o ?g. }

• W3141560986 endingPage "567" @default.
• W3141560986 startingPage "559" @default.
• W3141560986 abstract "Background Interval cancer rates can be used to evaluate whether screening with digital breast tomosynthesis (DBT) contributes to a screening benefit. Purpose To compare interval cancer rates and tumor characteristics in DBT screening to those in a contemporary population screened with digital mammography (DM). Materials and Methods The prospective population-based Malmö Breast Tomosynthesis Screening Trial (MBTST) was designed to compare one-view DBT to two-view DM in breast cancer detection. The interval cancer rates and cancer characteristics in the MBTST were compared with an age-matched contemporary control group, screened with two-view DM at the same center. Conditional logistic regression was used for data analysis. Results There were 14 848 women who were screened with DBT and DM in the MBTST between January 2010 and February 2015. The trial women were matched with two women of the same age and screening occasion at DM screening during the same period. Matches for 13 369 trial women (mean age, 56 years ± 10 [standard deviation]) were found with 26 738 women in the control group (mean age, 56 years ± 10). The interval cancer rate in the MBTST was 1.6 per 1000 screened women (21 of 13 369; 95% CI: 1.0, 2.4) compared with 2.8 per 1000 screened women in the control group (76 of 26 738 [95% CI: 2.2, 3.6]; conditional odds ratio, 0.6 [95% CI: 0.3, 0.9]; P = .02). The invasive interval cancers in the MBTST and in the control group showed in general high Ki-67 (63% [12 of 19] and 75% [54 of 72]), and low proportions of luminal A—like subtype (26% [five of 19] and 17% [12 of 72]), respectively. Conclusion The reduced interval cancer rate after screening with digital breast tomosynthesis compared with a contemporary age-matched control group screened with digital mammography might translate into screening benefits. Interval cancers in the trial generally had nonfavorable characteristics. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Mann in this issue." @default.
• W3141560986 created "2021-04-13" @default.
• W3141560986 creator A5003479498 @default.
• W3141560986 creator A5015335977 @default.
• W3141560986 creator A5024257120 @default.
• W3141560986 creator A5051751682 @default.
• W3141560986 creator A5051798546 @default.
• W3141560986 creator A5077008266 @default.
• W3141560986 date "2021-06-01" @default.
• W3141560986 modified "2023-10-02" @default.
• W3141560986 title "Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmö Breast Tomosynthesis Screening Trial" @default.
• W3141560986 cites W1922785252 @default.
• W3141560986 cites W2066568878 @default.
• W3141560986 cites W2116825371 @default.
• W3141560986 cites W2117775530 @default.
• W3141560986 cites W2118661096 @default.
• W3141560986 cites W2123869011 @default.
• W3141560986 cites W2124781356 @default.
• W3141560986 cites W2131756199 @default.
• W3141560986 cites W2163237523 @default.
• W3141560986 cites W2276152551 @default.
• W3141560986 cites W2290344319 @default.
• W3141560986 cites W2294753700 @default.
• W3141560986 cites W2460750615 @default.
• W3141560986 cites W2751398808 @default.
• W3141560986 cites W2778125810 @default.
• W3141560986 cites W2787183641 @default.
• W3141560986 cites W2789701020 @default.
• W3141560986 cites W2804133795 @default.
• W3141560986 cites W2807016245 @default.
• W3141560986 cites W2810806295 @default.
• W3141560986 cites W2885655595 @default.
• W3141560986 cites W2896522127 @default.
• W3141560986 cites W2915507740 @default.
• W3141560986 cites W2918601053 @default.
• W3141560986 cites W2944758817 @default.
• W3141560986 cites W2950655939 @default.
• W3141560986 cites W2971974709 @default.
• W3141560986 cites W2978467478 @default.
• W3141560986 cites W2994766824 @default.
• W3141560986 doi "https://doi.org/10.1148/radiol.2021204106" @default.
• W3141560986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33825509" @default.
• W3141560986 hasPublicationYear "2021" @default.
• W3141560986 type Work @default.
• W3141560986 sameAs 3141560986 @default.
• W3141560986 citedByCount "36" @default.
• W3141560986 countsByYear W31415609862021 @default.
• W3141560986 countsByYear W31415609862022 @default.
• W3141560986 countsByYear W31415609862023 @default.
• W3141560986 crossrefType "journal-article" @default.
• W3141560986 hasAuthorship W3141560986A5003479498 @default.
• W3141560986 hasAuthorship W3141560986A5015335977 @default.
• W3141560986 hasAuthorship W3141560986A5024257120 @default.
• W3141560986 hasAuthorship W3141560986A5051751682 @default.
• W3141560986 hasAuthorship W3141560986A5051798546 @default.
• W3141560986 hasAuthorship W3141560986A5077008266 @default.
• W3141560986 hasConcept C121608353 @default.
• W3141560986 hasConcept C126322002 @default.
• W3141560986 hasConcept C131872663 @default.
• W3141560986 hasConcept C143998085 @default.
• W3141560986 hasConcept C156957248 @default.
• W3141560986 hasConcept C188816634 @default.
• W3141560986 hasConcept C2778491387 @default.
• W3141560986 hasConcept C2780472235 @default.
• W3141560986 hasConcept C2908647359 @default.
• W3141560986 hasConcept C29456083 @default.
• W3141560986 hasConcept C44249647 @default.
• W3141560986 hasConcept C530470458 @default.
• W3141560986 hasConcept C71924100 @default.
• W3141560986 hasConcept C99454951 @default.
• W3141560986 hasConceptScore W3141560986C121608353 @default.
• W3141560986 hasConceptScore W3141560986C126322002 @default.
• W3141560986 hasConceptScore W3141560986C131872663 @default.
• W3141560986 hasConceptScore W3141560986C143998085 @default.
• W3141560986 hasConceptScore W3141560986C156957248 @default.
• W3141560986 hasConceptScore W3141560986C188816634 @default.
• W3141560986 hasConceptScore W3141560986C2778491387 @default.
• W3141560986 hasConceptScore W3141560986C2780472235 @default.
• W3141560986 hasConceptScore W3141560986C2908647359 @default.
• W3141560986 hasConceptScore W3141560986C29456083 @default.
• W3141560986 hasConceptScore W3141560986C44249647 @default.
• W3141560986 hasConceptScore W3141560986C530470458 @default.
• W3141560986 hasConceptScore W3141560986C71924100 @default.
• W3141560986 hasConceptScore W3141560986C99454951 @default.
• W3141560986 hasIssue "3" @default.
• W3141560986 hasLocation W31415609861 @default.
• W3141560986 hasOpenAccess W3141560986 @default.
• W3141560986 hasPrimaryLocation W31415609861 @default.
• W3141560986 hasRelatedWork W1971803455 @default.
• W3141560986 hasRelatedWork W1973855633 @default.
• W3141560986 hasRelatedWork W1996753309 @default.
• W3141560986 hasRelatedWork W2032808049 @default.
• W3141560986 hasRelatedWork W2120803900 @default.
• W3141560986 hasRelatedWork W2224319365 @default.
• W3141560986 hasRelatedWork W2910304319 @default.
• W3141560986 hasRelatedWork W3026273959 @default.
• W3141560986 hasRelatedWork W3135824106 @default.
• W3141560986 hasRelatedWork W4312215125 @default.

• next